This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2022 Information Coming Soon!

Gernot Stuhler, MD
Immunotherapy Lab at University Hospital Würzburg

Profile

Gernot Stuhler is a haematologist/oncologist with a strong background in allogeneic stem cell transplantation. He was trained in Immunology at the Max-Planck-Institute in Tübingen and at the Dana Farber Cancer Institute/Harvard Medical School in Boston. During his time at Würzburg University where bispecific T cell engager were clinically developed, he got involved in antibody engineering. Currently, he is heading a group of scientists aiming to improve T cell engaging antibody derivatives and to implement combinatorial immunotargeting strategies.

Agenda Sessions

  • Advances in T-Cell Engaging Therapies

    12:30
  • Ultra-precise Immunotherapy by Hemibodies

    On Demand